09:13 AM EDT, 11/01/2024 (MT Newswires) -- Biodesix ( BDSX ) said in a regulatory filing Friday that some stockholders are selling up to 62.2 million of their shares.

The selling stockholders include entities related to Biodesix's ( BDSX ) board directors: Westwood Management's chief executive officer Lawrence Kennedy Jr., Crabtree Partners' co-founders Jack Schuler and John Patience, as well as Birchview Capital's managing partner Matthew Strobeck, the filing showed.

Biodesix ( BDSX ) said it will not receive any proceeds from the sale.

Separately, Biodesix ( BDSX ) filed a registration statement to sell up to $250 million in securities from time to time.

The filing includes the sale of the company's common stock, preferred stock, warrants and units, as well as rights to purchase these securities.